Kirkland & Ellis represented iMotion Automotive Technology (Suzhou) Co., Ltd. on the transaction. iMotion Automotive Technology (Suzhou) Co., Ltd. (“iMotion”) announced its H-share placing (the “H-Share...
iMotion’s Shares Placement
ImmuneOnco Biopharmaceuticals’ HK$234 Million Shares Placement
Kirkland & Ellis represented the sole overall coordinator and placing agent, China International Capital Corporation Hong Kong Securities Limited, in the transaction. ImmuneOnco Biopharmaceuticals (Shanghai) Inc....
BingEx Limited’s $66 Million IPO
Skadden, Arps, Slate, Meagher & Flom represented BingEx Limited in the offering, and Maples and Calder (Hong Kong) represented the company under the Cayman Islands Law....
Genor Biopharma’s Merger with Edding
Kirkland & Ellis is representing Edding Group Company Limited on the transaction, and Haiwen is representing Genor Biopharma. Edding Group Company Limited agreed to acquire Genor...
Super Hi’s IPO
Kirkland & Ellis represented Super Hi International Holding Ltd. in the offering. Super Hi International Holding Ltd. (“Super Hi”), the overseas operator of Chinese hot pot...
Kelun-Biotech Biopharmaceutical’s H-Share Placing
Kirkland & Ellis represented the placing agents in the deal. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (“Kelun-Biotech”) announced it completed the H-share placing (the “H-Share Placing”). Kelun-Biotech...
Will Semiconductor Co.’s $444.9 Million GDR Offering and Listing on SIX Swiss Exchange
Kirkland & Ellis and Advestra advised Will Semiconductor Co., Ltd. Shanghai on the offering. Clifford Chance and Niederer Kraft Frey advised J.P. Morgan Securities plc and...
ZX Inc.’s HK$266 Million Hong Kong IPO
Kirkland & Ellis, Beijing Dacheng Law Offices, LLP, Goldsun Law Firm and Walkers (Hong Kong) represented ZX Inc., and Wilson Sonsini Goodrich & Rosati and JunHe...
ImmuneOnco Biopharmaceuticals’ HK$319 Million IPO
Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
Bain Capital Private Equity’s $400 Million Equity Investment in EcoCeres
Kirkland & Ellis advised Bain Capital Private Equity on the deal. Bain Capital Private Equity announced its significant equity investment in EcoCeres. EcoCeres is incubated by The Hong...
Super Hi’s Spin-off and Separate Listing
Kirkland & Ellis advised on Hong Kong law, Jingtian & Gongcheng advised on PRC law, Conyers Dill & Pearman advised on Cayman Islands law, Drew &...
Suzhou Ribo Life Science’s $40 Million Series E1 Financing Round
Kirkland & Ellis advised Suzhou Ribo Life Science Co., Ltd. on the transaction. Suzhou Ribo Life Science Co., Ltd. (Ribo), a clinical stage company developing innovative...